Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial
Cortes, Jorge E, De Souza, Carmino Antonio, Ayala, Manuel, Lopez, Jose Luis, Bullorsky, Eduardo, Shah, Sandip, Huang, Xiaojun, Babu, K Govind, Abdulkadyrov, Kudrat, de Oliveira, José Salvador Rodrigues, Shen, Zhi-Xiang, Sacha, Tomasz, Bendit, Israel, Liang, Zhizhou, Owugah, Tina, Szczudlo, Tomasz, Khanna, Sadhvi, Fellague-Chebra, Rafik, le Coutre, Philipp D
Published in The Lancet. Haematology (01.12.2016)
Published in The Lancet. Haematology (01.12.2016)
Get more information
Journal Article
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial
Garon, Edward B, Lu, Shun, Goto, Yasushi, De Marchi, Pedro, Paz-Ares, Luis, Spigel, David R, Thomas, Michael, Yang, James Chih-Hsin, Ardizzoni, Andrea, Barlesi, Fabrice, Orlov, Sergey, Yoshioka, Hiroshige, Mountzios, Giannis, Khanna, Sadhvi, Bossen, Claudia, Carbini, Mariana, Turri, Sabine, Myers, Andrea, Cho, Byoung Chul
Published in Journal of clinical oncology (10.01.2024)
Published in Journal of clinical oncology (10.01.2024)
Get full text
Journal Article
Capmatinib plus osimertinib versus platinum-pemetrexed doublet chemotherapy as second-line therapy in patients with stage IIIb/IIIc or IV EGFR -mutant, T790M-negative NSCLC harboring MET amplification
Wu, Yi-Long, Han, Ji-Youn, Kato, Terufumi, Barlesi, Fabrice, Garon, Edward B., Cappuzzo, Federico, Shibata, Yuji, Smith, Nathalie, Khanna, Sadhvi, Belli, Riccardo, Yovine, Alejandro Javier, Tan, Daniel S.W.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A five‐year follow‐up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial
Offner, Fritz, Robak, Tadeusz, Janssens, Ann, Govind Babu, K., Kloczko, Janusz, Grosicki, Sebastian, Mayer, Jiri, Panagiotidis, Panagiotis, Schuh, Anna, Pettitt, Andrew, Montillo, Marco, Werner, Olena, Vincent, Ghislaine, Khanna, Sadhvi, Hillmen, Peter
Published in British journal of haematology (01.09.2020)
Published in British journal of haematology (01.09.2020)
Get full text
Journal Article
Long-term follow-up of previously untreated patients (pts) with chronic lymphocytic leukemia (CLL) treated with ofatumumab (OFA) and chlorambucil (CHL): Final analysis of the phase 3 COMPLEMENT 1 trial
Offner, Fritz, Robak, Tadeusz, Janssens, Ann, Kanakasetty, Govind Babu, Kloczko, Janusz, Grosicki, Sebastian, Mayer, Jiri, Panagiotidis, Panagiotis, Schuh, Anna, Pettitt, Andrew, Montillo, Marco, Werner, Olena, Vincent, Ghislaine, Khanna, Sadhvi, Hillmen, Peter
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Abstract CT559: Capmatinib plus osimertinib vs platinum-pemetrexed doublet chemotherapy as second-line therapy in patients with stage IIIB/IIIC or IV EGFR -mutant, T790M-negative NSCLC harboring MET amplification
Wu, Yi-Long, Han, Ji-Youn, Kato, Terufumi, Barlesi, Fabrice, Garon, Edward B., Cappuzzo, Federico, Shibata, Yuji, Smith, Nathalie, Khanna, Sadhvi, Belli, Riccardo, Yovine, Alejandro, Tan, Daniel
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study
Hughes, Timothy P., Salvino, Marco Aurelio, Chuan, Ong Tee, Elhaddad, Alaa, Abdulkadyrov, Kudrat, Shortt, Jake, Quach, Hang, Pavlovsky, Carolina, Louw, Vernon J., Shih, Lee-Yung, Turkina, Anna G., Meillon, Luis, Jin, Yu, Khanna, Sadhvi, Dalal, Darshan, Lipton, Jeffrey H.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Safety and Efficacy of Ruxolitinib for the Final Enrollment of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (N = 2233)
Foltz, Lynda, Palumbo, Giuseppe A., Martino, Bruno, Palandri, Francesca, Al-Ali, Haifa Kathrin, Liberati, Anna Marina, Le Coutre, Philipp D., Vannucchi, Alessandro M., Garcia-Hernandez, Carmen, Tavares, Renato, Griesshammer, Martin, Gupta, Vikas, Raanani, Pia, Giraldo, Pilar, Bouard, Catherine, Perez Ronco, Julian, Khanna, Sadhvi, Zaritskey, Andrey
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article